Feng FY - Search Results

1

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.

Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. Dess RT, et al. Among authors: feng fy. JAMA Oncol. 2020 May 1;6(5):735-743. doi: 10.1001/jamaoncol.2020.0109. JAMA Oncol. 2020. PMID: 32215583 Free PMC article. Clinical Trial.

2

The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy.

Qian Y, Feng FY, Halverson S, Blas K, Sandler HM, Hamstra DA. Qian Y, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e135-42. doi: 10.1016/j.ijrobp.2011.01.007. Epub 2011 Feb 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 21345617

3

Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation.

Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, Hamstra DA. Sabolch A, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e351-60. doi: 10.1016/j.ijrobp.2011.01.063. Epub 2011 Apr 13. Int J Radiat Oncol Biol Phys. 2011. PMID: 21493015

4

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.

Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA. Stenmark MH, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e335-44. doi: 10.1016/j.ijrobp.2011.04.037. Epub 2011 Jun 7. Int J Radiat Oncol Biol Phys. 2011. PMID: 21645976

5

The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse.

Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA. Halverson S, et al. Among authors: feng fy. Radiother Oncol. 2011 Dec;101(3):513-20. doi: 10.1016/j.radonc.2011.05.080. Epub 2011 Jun 22. Radiother Oncol. 2011. PMID: 21703711

6

Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy.

Feng FY, Qian Y, Stenmark MH, Halverson S, Blas K, Vance S, Sandler HM, Hamstra DA. Feng FY, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e361-7. doi: 10.1016/j.ijrobp.2011.04.048. Epub 2011 Aug 4. Int J Radiat Oncol Biol Phys. 2011. PMID: 21820250

7

Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer.

Kapadia NS, Olson K, Sandler HM, Feng FY, Hamstra DA. Kapadia NS, et al. Among authors: feng fy. Cancer. 2012 Apr 15;118(8):2059-68. doi: 10.1002/cncr.26498. Epub 2011 Aug 26. Cancer. 2012. PMID: 22009287 Free article.

8

Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A. Little M, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1007-14. doi: 10.1016/j.ijrobp.2011.09.004. Epub 2011 Nov 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 22056067 Free PMC article.

9

Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.

Vance SM, Stenmark MH, Blas K, Halverson S, Hamstra DA, Feng FY. Vance SM, et al. Among authors: feng fy. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):940-6. doi: 10.1016/j.ijrobp.2011.09.005. Epub 2011 Nov 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 22056069

10

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.

Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, Hamstra DA. Murgic J, et al. Among authors: feng fy. Radiat Oncol. 2012 Aug 1;7:127. doi: 10.1186/1748-717X-7-127. Radiat Oncol. 2012. PMID: 22852797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page